HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Candidiasis D002177 3 associated lipids
Heart Arrest D006323 13 associated lipids
HIV Infections D015658 20 associated lipids
Rabies D011818 4 associated lipids
Cerebellar Neoplasms D002528 9 associated lipids
Medulloblastoma D008527 22 associated lipids
Neurilemmoma D009442 10 associated lipids
Spinal Cord Neoplasms D013120 3 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Costa-Nogueira C et al. Synthesis and expression of CDw75 antigen in human colorectal cancer. 2009 BMC Cancer pmid:20003255
Zhang B et al. Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. 2009 BMC Cancer pmid:19995435
Kahlert C et al. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. 2011 BMC Cancer pmid:21708005
Pinho SS et al. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression. 2007 BMC Cancer pmid:17617904
de Kruijf EM et al. NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study. 2012 BMC Cancer pmid:22257486
Wang Q et al. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. 2011 BMC Cancer pmid:21702992
Chaube A et al. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582. 2006 BMC Cancer pmid:16686942
Morgan K et al. GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines. 2011 BMC Cancer pmid:22051164
Hamtiaux L et al. The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action. 2012 BMC Cancer pmid:22429826
Kalinina T et al. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. 2010 BMC Cancer pmid:20553613
Kim JH et al. Canine classical seminoma: a specific malignant type with human classifications is highly correlated with tumor angiogenesis. 2010 BMC Cancer pmid:20509912
Di Nicolantonio F et al. Cancer cell adaptation to chemotherapy. 2005 BMC Cancer pmid:16026610
Egerod FL et al. High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. 2009 BMC Cancer pmid:19878561
Kalliomäki TM et al. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. 2008 BMC Cancer pmid:18507854
González-Reyes S et al. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. 2010 BMC Cancer pmid:21129170
Kratz JE et al. Expression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation. 2002 BMC Cancer pmid:12460454
Chen M et al. Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instability. 2011 BMC Cancer pmid:21612665
Muinelo-Romay L et al. Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer. 2011 BMC Cancer pmid:22152070
Kavanagh DO et al. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? 2009 BMC Cancer pmid:19118499
Tong QS et al. BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells. 2004 BMC Cancer pmid:15248898
Chanrion M et al. A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study. 2007 BMC Cancer pmid:17338809
Nordfors K et al. The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis. 2010 BMC Cancer pmid:20398423
Wu Z et al. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. 2009 BMC Cancer pmid:19732464
Brennan DJ et al. Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer. 2010 BMC Cancer pmid:20359358
Sun S et al. A protein-based set of reference markers for liver tissues and hepatocellular carcinoma. 2009 BMC Cancer pmid:19725976
Nordentoft I et al. Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. 2011 BMC Cancer pmid:21489314
Woelber L et al. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer. 2011 BMC Cancer pmid:21223596
Szybka M et al. cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer. 2009 BMC Cancer pmid:19671129
Shi H et al. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis. 2010 BMC Cancer pmid:20815902
Spindler KL et al. EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer. 2011 BMC Cancer pmid:21439039
Nykopp TK et al. Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. 2010 BMC Cancer pmid:20875124
Hung MS et al. Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library. 2009 BMC Cancer pmid:19419583
Naguib A et al. Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study. 2010 BMC Cancer pmid:20233436
Van der Auwera I et al. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. 2010 BMC Cancer pmid:20226036
Nyalendo C et al. Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression. 2009 BMC Cancer pmid:19961596
Tomlinson VA et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. 2005 BMC Cancer pmid:16156888
Ihnen M et al. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients. 2012 BMC Cancer pmid:22475274
Mascolo M et al. Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. 2010 BMC Cancer pmid:20178651
Zhao C et al. Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer. 2009 BMC Cancer pmid:19586554
Bedin V et al. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma. 2010 BMC Cancer pmid:20525386
Malfettone A et al. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis. 2012 BMC Cancer pmid:22439624
Schneider M et al. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker. 2012 BMC Cancer pmid:22433494
van Cruijsen H et al. Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. 2009 BMC Cancer pmid:19519895
Dierssen JW et al. High-resolution analysis of HLA class I alterations in colorectal cancer. 2006 BMC Cancer pmid:17014712
Gonzalez LO et al. Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. 2008 BMC Cancer pmid:18507821
Kumar MJ et al. A mouse model for luminal epithelial like ER positive subtype of human breast cancer. 2007 BMC Cancer pmid:17880731
Xiaorong L et al. Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma. 2008 BMC Cancer pmid:18651974
Zavagno G et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. 2005 BMC Cancer pmid:15762990
Bacman D et al. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. 2007 BMC Cancer pmid:17692120
Macartney-Coxson DP et al. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. 2008 BMC Cancer pmid:18590575